Ignacio Ferreira González
- Genetics top 2%
- Glioma Diagnosis and Treatment 4
- Hematology top 10%
- Pharmaceutical Science top 10%
- Neurology top 10%
- Neuroblastoma Research and Treatments 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Lipoproteins and Cardiovascular Health 4
-
- Cardiac Imaging and Diagnostics 3
-
- Crystallization and Solubility Studies 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Statistical Methods in Clinical Trials 3
- Co-authors
- Gerard UrrútiaPablo Alonso‐CoelloMarvin D. NelsonJohn C. WoodJ. Gordon McCombSteven L. GiannottaJonathan L. FinlayCathleen Enriquez
- Journals
- Circulation (1 paper)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Ignacio Ferreira González
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 145
- Genetics 351
- Hematology 146
- Pharmaceutical Science 55
- Neurology 121
- Oncology 179
Countries citing papers authored by Ignacio Ferreira González
This map shows the geographic impact of Ignacio Ferreira González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Ferreira González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Ferreira González more than expected).
Fields of papers citing papers by Ignacio Ferreira González
This network shows the impact of papers produced by Ignacio Ferreira González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Ferreira González. The network helps show where Ignacio Ferreira González may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ignacio Ferreira González, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 28 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 40 | |
| 10 | 2020 | 8 | |
| 11 | 2018 | 27 | |
| 12 | 2018 | 20 | |
| 13 | 2017 | 5 | |
| 14 | 2016 | 9 | |
| 15 | 2015 | 1 | |
| 16 | 2011 | 52 | |
| 17 | 2011 | 118 | |
| 18 | 2006 | 63 | |
| 19 | 2006 | 102 | |
| 20 | 2004 | 23 |
About Ignacio Ferreira González
Ignacio Ferreira González is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Statistics and Probability, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Cardiac Imaging and Diagnostics (3 papers), Crystallization and Solubility Studies (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Statistical Methods in Clinical Trials (3 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Genetics (351 citations), Hematology (146 citations) and Pharmaceutical Science (55 citations). Ignacio Ferreira González has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Gerard Urrútia, Pablo Alonso‐Coello, Marvin D. Nelson, John C. Wood, J. Gordon McComb, Steven L. Giannotta, Jonathan L. Finlay, Cathleen Enriquez, Nilesh R. Ghugre and Thomas D. Coates. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.